HAKY yields 3.21% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, HAKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HAKY + JNJ for your $10,000?
HAKY combines thematic equity exposure with an options overlay by investing primarily in the equity securities held by the Amplify Cybersecurity ETF. The underlying exposure focuses on companies whose revenues are largely derived from the cybersecurity products and services, including both infrastructure and service providers. To generate income, the fund writes exchange-traded covered call options on individual equity holdings and, at times, on the underlying ETF, generally using options with maturities of one month or less. Premiums received from option writing are intended to support monthly distributions, though amounts may vary and a portion may be classified as return of capital. By selling call options, the fund limits participation in equity gains above the option strike prices in exchange for current income. In certain market conditions, the fund may employ covered call spreads to allow for some additional upside participation while still generating net option income.
Full HAKY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.